| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/04/2011 | US20110189123 Mammalian cx3c chemokine antibodies |
| 08/04/2011 | US20110189106 Intranasal compositions, dosage forms and methods of treatment |
| 08/04/2011 | US20110189092 Polymer-agent conjugates, particles, compositions, and related methods of use |
| 08/04/2011 | US20110189082 Human gm-csf antigen binding proteins |
| 08/04/2011 | CA2788224A1 Pyrazole compounds as crth2 antagonists |
| 08/04/2011 | CA2787321A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | CA2787315A1 Pyrazolopyridine kinase inhibitors |
| 08/04/2011 | CA2787070A1 Cd127 binding proteins |
| 08/04/2011 | CA2786994A1 Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
| 08/04/2011 | CA2784571A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 08/03/2011 | EP2351836A1 Double-stranded oligonucleotides |
| 08/03/2011 | EP2351765A2 Oligonucleotide-containing pharmacological compositions and their use |
| 08/03/2011 | EP2351754A1 Phenanthroindolizidine compound and nf b inhibitor containing same as active ingredient |
| 08/03/2011 | EP2351570A1 An Antibiotic/Analgesic Formulation And a Method of Making This Formulation |
| 08/03/2011 | EP2351566A1 Pharmaceutical composition improved in absorption through intestinal tract |
| 08/03/2011 | EP2351565A1 Medicine for preventing or treating pain related to herpes zoster |
| 08/03/2011 | EP2351563A1 Agent for treatment of diabetes |
| 08/03/2011 | EP2351561A2 Novel methods and compositions for alleviating pain |
| 08/03/2011 | EP2351557A1 Thin film with non-self-aggregating uniform heterogeneity, process for ther production and drug delivery systems made therefrom |
| 08/03/2011 | EP2350091A1 Spiro-oxindole compounds and their use as therapeutic agents |
| 08/03/2011 | EP2350076A2 Imidazoý1,2- ¨pyridinyl bisphosphonates |
| 08/03/2011 | EP2350075A1 Substituted imidazoý1,2b¨pyridazine compounds as trk kinase inhibitors |
| 08/03/2011 | EP2350073A1 3H-IMIDAZO[4,5-b]PYRIDINE-6-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS |
| 08/03/2011 | EP2350071A1 SUBSTITUTED PYRAZOLOÝ1,5-a¨PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS |
| 08/03/2011 | EP2350064A1 Compounds for inflammation and immune-related uses |
| 08/03/2011 | EP2350060A2 Melanocortin receptor agonists |
| 08/03/2011 | EP2350051A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators |
| 08/03/2011 | EP2350049A2 P38 map kinase inhibitors |
| 08/03/2011 | EP2350047A2 P38 map kinase inhibitors |
| 08/03/2011 | EP2350004A1 Compounds for inflammation and immune-related uses |
| 08/03/2011 | EP2350003A1 Substituted disulfonamides as bri-modulators |
| 08/03/2011 | EP2349990A1 Aryl-phenyl-sulfonamide-phenylene compounds and their use |
| 08/03/2011 | EP2349964A2 Dibenzocycloheptanone derivatives and pharmaceutical agents containing said compounds |
| 08/03/2011 | EP2349321A1 Annexin and its use to treat inflammatory disorders |
| 08/03/2011 | EP2349285A2 Methods for treating or preventing pain using spicamycin derivatives |
| 08/03/2011 | EP2349281A1 Composition comprising a glycoside of a mono- or diacyiglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition |
| 08/03/2011 | EP2349277A2 Methods of identification of novel ligands for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (nr1f3) activity |
| 08/03/2011 | EP2349250A1 Fatty acids for use as a medicament |
| 08/03/2011 | EP2349248A2 Topical nsaid compositions having sensate component |
| 08/03/2011 | EP2349241A1 Pharmaceutical compositions with attenuated release of phenolic opioids |
| 08/03/2011 | EP2349239A1 Detection and use of low molecular-weight modulators of the cold-menthol receptor trpm8 |
| 08/03/2011 | EP2349238A1 Co-crystals of tramadol and nsaids |
| 08/03/2011 | EP2220059B1 2-aminooxazole derivatives as trpvl antagonists useful for treating pain |
| 08/03/2011 | EP2125782B1 Aryl carboxylic acid cyclohexyl amide derivatives |
| 08/03/2011 | EP2117552B1 Use of condensed pyrimidine derivatives for the treatment of autoimmune and inflammatory diseases |
| 08/03/2011 | EP2114970B1 Tricyclic compounds and their use as glucocorticoid receptor modulators |
| 08/03/2011 | EP1948638B1 Compounds for the treatment of inflammatory disorders |
| 08/03/2011 | EP1853587B1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity |
| 08/03/2011 | EP1809268B1 Alpha-humulene for use in the prophylaxis or treatment of inflammatory pain or oedema |
| 08/03/2011 | EP1534753B1 Peg positional isomer of an anti-tnfalpha antibody (cdp870) |
| 08/03/2011 | EP1446104B2 Spray drying methods |
| 08/03/2011 | EP1317282B1 Vectors for molecule delivery to cd11b expressing cells |
| 08/03/2011 | CN1891687B Inflammatory factor receptor antagonistic active compound from microbe and its use |
| 08/03/2011 | CN1890218B Tubulin inhibitors |
| 08/03/2011 | CN1729160B Drugs for chronic pain |
| 08/03/2011 | CN1700934B Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 08/03/2011 | CN102143946A Calcium ion channel modulators & uses thereof |
| 08/03/2011 | CN102143942A Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors |
| 08/03/2011 | CN102143750A Macrocyclics pyrimidines as aurora kinase inhibitors |
| 08/03/2011 | CN102140104A 1-(3-(S)-amino propyl)-piperidine-4-aminoacid amide compound and pharmaceutical composition thereof as well as preparation methods and applications of compound and pharmaceutical composition |
| 08/03/2011 | CN102140090A Dipeptidyl peptidase inhibitors |
| 08/03/2011 | CN102140081A Process for the preparation of indazolyl ureas that inhibit vanilloid subtype 1 (VR1) receptors |
| 08/03/2011 | CN102139099A Therapeutic composition with a botulinum neurotoxin |
| 08/03/2011 | CN102139094A Application of long-chain neurotoxin of cobra in preparation of muscarine type M4 receptor activator |
| 08/03/2011 | CN102139093A Application of short-chain cobrotoxin in preparation of intrathecally administrated analgesic medicines |
| 08/03/2011 | CN102139088A Cervical and lumbar vertebrae rehabilitation pill |
| 08/03/2011 | CN102139087A Medicament for treating rheumatoid arthritis and preparation method thereof |
| 08/03/2011 | CN102139048A Quality control method of tablet capable of improving eyesight and clearing heat |
| 08/03/2011 | CN102139046A Quality control method for antidotal forsythia tablet |
| 08/03/2011 | CN102139032A Traditional Chinese medicine for treating intervertebral disc protrusion, hyperosteogeny and rheumatoid disease |
| 08/03/2011 | CN102139027A Medicinal liquor for treating rheumatic arthritis |
| 08/03/2011 | CN102139022A Medicament for treating lumbar intervertebral disc protrusion and rheumatism |
| 08/03/2011 | CN102139020A Medicament for treating influenza and bad cold and preparation method thereof |
| 08/03/2011 | CN102139003A Plaster for treating furuncle and joint swelling and heat and application thereof |
| 08/03/2011 | CN102139002A Cortex phellodendri polysaccharide extract and preparation method and medical application thereof |
| 08/03/2011 | CN102138986A Medicated bath material for treating rheumatism and gout and preparation method thereof |
| 08/03/2011 | CN102138978A Quality control method for mongolian dandelion herb corydalis and indigowoad root-containing inflammation diminishing tablets |
| 08/03/2011 | CN102138960A Novel extraction process of dalbergiae oil through super (sub) critical carbon dioxide |
| 08/03/2011 | CN102138951A Preparation method of gynura japonica alkaloid |
| 08/03/2011 | CN102138945A Method of extracting active substances with high content of flavones from ginkgo leaves |
| 08/03/2011 | CN102138940A Preparation method of termitarium capsule |
| 08/03/2011 | CN102138900A Solid preparation of oxapium iodide liposome |
| 08/03/2011 | CN102138893A Preparation process and use of sodium lysinrofen chloride injection |
| 08/03/2011 | CN102138891A Ketorolac tromethamine injection |
| 08/03/2011 | CN101766706B Medicinal combination containing borneol and musk |
| 08/03/2011 | CN101766705B Medicinal combination containing borneol and musk |
| 08/03/2011 | CN101766704B Medicinal combination containing borneol and musk |
| 08/03/2011 | CN101766703B Medicinal combination containing borneol and musk |
| 08/03/2011 | CN101766702B Medicinal combination containing borneol and musk |
| 08/03/2011 | CN101766701B Medicinal combination containing musk |
| 08/03/2011 | CN101766700B Medicinal combination containing musk |
| 08/03/2011 | CN101766699B Medicinal combination containing musk |
| 08/03/2011 | CN101732229B Borneol inclusion compound and preparation method thereof |
| 08/03/2011 | CN101690797B Traditional Chinese medicine for treating rheumatism and rheumatoid diseases |
| 08/03/2011 | CN101618019B Triamcinolone acetonide acetate particle, and preparation method and medicinal composition thereof |
| 08/03/2011 | CN101495632B Humanized anti-human osteopontin antibody |
| 08/03/2011 | CN101491616B Preparation method of traditional Chinese medicine granules capable of relieving exterior syndrome, dispelling coldness and dispersing dampness |
| 08/03/2011 | CN101474315B Effective component group of stem-bark or root-bark of Daphne giraldii as well as preparation method and use thereof |
| 08/03/2011 | CN101461828B Method for preparing extract of Usnea diffracta Vain |
| 08/03/2011 | CN101431990B Pharmaceutical combination comprising 3-(3-dimethylamino-1-ethyl-2-methyl-propyl) -phenol and paracetamol |